Annual Congress Vienna 2003

Saturday, 27.09.2003
Sunday, 28.09.2003
Monday, 29.09.2003
Tuesday, 30.09.2003
Wednesday, 01.10.2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

3196 Abstracts
374 Slide presentations

Material from 2003: Show

"Asthma: inhaled therapy; allergic bronchopulmonary aspergillosis"

Thematic Poster Session
Chairs: T. Pertseva (Dniepropetrovsk, Ukraine), K. Stanislav (Celje, Slovenia)

Download all media

As-needed formoterol has an improved safety profile compared with as-needed terbutaline in mild intermittent asthma A. G. Chuchalin, I. Makarova, P. Bergqvist (Moscow, St Petersburg, Russia; Lund, Sweden)
Formoterol as relief medication is increasingly more effective than salbutamol in patients with increasing need for reliever therapy H. C. J. van Klink, D. Cheung, R. Aalbers (Leiden, Schiedam, Groningen, The Netherlands)
Salmeterol/fluticasone combination (SFC) is associated with improved asthma control compared with concurrent long-acting β₂ agonists (LABA) and inhaled corticosteroids (ICS) or ICS alone P. McCarthy, L. Rice, C. A. Blair (Uxbridge, United Kingdom)
Long-term clinical management with the salmeterol/fluticasone propionate combination, fluticasone propionate and sameterol in a 'real-life' study B. Lundback, E. Ronmark, A. C. Jonsson, L. G. Larsson, A. Lindberg, M. H. James (Stockholm, Lulea, Sweden; Greenford, United Kingdom)
*12 weeks comparing salmeterol/fluticasone proprionate (SFC, 50/100 microg b.d.* diskus) versus fluticasone proprionate (FP, 250 microg b.i.diskus) as first-line regular asthma treatment** T. Oien, B. Tilling, J. Kotaniemi (Trondheim, Norway; Atvidaberg, Sweden; Lahti, Finland)
Relative potency of beclomethasone propionate (BDP), delivered by HFA-MDI, and fluticasone propionate (FP) delivered by diskus R. C. Ahrens, L. Hendeles, M. E. Teresi, C. R. Lux, J. Vanden Burgt, K. A. Hart, B. P. Ekholm (Iowa City, Gainesville, St. Paul, United States Of America)
The relevance of the delivery system to the efficacy of the association beta2 agonists/steroids in asthma R. Pistelli, F. Baldari, S. Sammarro (Rome, Italy)
Correct use and acceptability of three devices: a comparison between easyhaler, discus and turbuhaler E. Rönmark, R. Jögi, A. Lindqwist, M. Meren, H. M. Loit, U. Sairanen, B. Lundbäck (Luleå, Stockholm, Sweden; Tartu, Tallinn, Estonia; Helsinki, Koupio, Finland)
*An in vitrocomparison of two dry powder inhalers after storage in hot and humid conditions* P. Lipniunas, L. Asking (Lund, Sweden)
Budesonide/formoterol in Turbuhaler© is not affected by storage in hot and humid conditions. A clinical pharmacokinetic comparison with fluticasone/salmeterol in DiskusÔ L. Borgström, P. Lipniunas (Lund, Sweden)
Use of hydrofluoroalkane beclomethasone dipropionate (HFA-BDP) extrafine aerosol in optimising the management of allergic bronchopulmonary aspergillosis (ABPA) J. M. FitzGerald (Vancouver, Canada)
Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy D. Kirsten, A. Ludwig-Sengpiel, H. Magnussen (Grosshansdorf, Germany)